Efficacy and safety of indacaterol/glycopyrronium fixed-dose combination in mild-to-moderate COPD patients symptomatic on tiotropium in Korea: study protocol for a randomized controlled trial
Crossref DOI link: https://doi.org/10.1186/s13063-017-1800-3
Published Online: 2017-02-22
Published Print: 2017-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Rhee, Chin Kook
Park, Hye Yun
Park, Jeong-Woong
Lee, Ji-Hyun
Kim, Tae-Hyung
Lee, Sei Won
Jung, Ji Ye
Kim, Song
Hwang, Yong Il
Jung, Ki-Suck
Funding for this research was provided by:
Novartis Korea Ltd